Casper Breum, Director at Spero Therapeutics, Inc. (SPRO), bought 503,387 shares at $14.00 ($3.0M) on 2017-11-06, disclosed to the SEC on 2017-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 289,102 | $0 | 0.0% |
| 2 | $14.00 | 214,285 | $3.0M | 100.0% |
| Total | $5.96 avg | 503,387 | $3.0M | 100% |